SCHEMBL6049447

SCHEMBL6049447

N#CCc1ccc(I)cc1.NCCc1ccc(I)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 9/20 0.42
HTR2A P28223 4/20 0.42
CYP2A6 P11509 2/20 0.42
CYP1A2 P05177 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTR3A P46098 1/20 0.42
BACE1 P56817 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAOB P27338 3/20 0.37
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480922 0.85 CYP3A4 (0.41) CYP1A2KDM4EL3MBTL1KMT2ATDP1
SCHEMBL168309 0.83 TAAR1 (0.56) TAAR1HTR2ACYP2A6CYP1A2KDM4E
Phenethylamine SCHEMBL27558781 0.80 HTR2A (0.67) TAAR1HTR2ACYP2A6CYP1A2CYP2C19
SCHEMBL2154504 0.73 KMT2A (0.47) CYP2A6CYP1A2KDM4EL3MBTL1KMT2A
SCHEMBL2421870 0.73 MEN1 (0.52) CYP1A2ALDH1A1KMT2ATDP1CYP3A4
SCHEMBL3810558 0.72 LOXL2 (0.58) TAAR1KDM4EKMT2ATDP1LOXL2
SCHEMBL141424 0.72 TDP1 (0.50) KDM4EALDH1A1L3MBTL1KMT2ATDP1
SCHEMBL224548 0.71 TAAR1 (0.72) TAAR1HTR2ACYP2A6CYP1A2KDM4E
Hydrochloric Acid SCHEMBL20270668 0.70 TDP1 (0.48) KDM4EALDH1A1L3MBTL1KMT2ATDP1
SCHEMBL11221908 0.70 TAAR1 (0.52) TAAR1HTR2ACYP2A6CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641465-A2 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID Theravance, Inc. (US) 2006-04-05 EP disclosed
WO-2005025555-A2 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID THERAVANCE, INC. (US) 2005-03-24 WO disclosed
EP-1446379-A1 ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONISTS Theravance, Inc. (US) 2004-08-18 EP disclosed
WO-2003042164-A1 ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONISTS THERAVANCE, INC (US) 2003-05-22 WO disclosed